VistaGen Therapeutics, Inc. ( VTGN) - Key Metrics
VTGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0.01 | -$0.45 | -$0.42 | -$0.42 |
| 2026Q2 | $0.01 | -$0.54 | -$0.38 | -$0.39 |
| 2026Q1 | $0.01 | -$0.47 | -$0.59 | -$0.59 |
| 2025Q4 | $0 | -$0.44 | -$0.33 | -$0.33 |
| 2025Q3 | $0.01 | -$0.46 | -$0.33 | -$0.33 |
VTGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | -0.37 |
| 2026Q2 | ? | -1.63 |
| 2026Q1 | ? | -1.06 |
| 2025Q4 | ? | -1.41 |
| 2025Q3 | ? | -1.61 |
VTGN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | -62.85% | ? |
| 2026Q2 | -10.89% | ? |
| 2026Q1 | -29.51% | ? |
| 2025Q4 | -13.22% | ? |
| 2025Q3 | -11.35% | ? |
VTGN
Price: $0.58
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.90 USD
P/E Ratio: -0.33
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 11.3 million
Ebitda: -2.8 millionMarket Capitalization: 18.4 million